While MS is still considered rare in India, we’re now seeing a shift toward moderate prevalence,” Dr M V Padma told Business ...

Roche Holdings AG (OTC:RHHBY) on Friday announced new 96-week data for fenebrutinib demonstrating that patients with ...

Scientists at the University Medical Center Hamburg-Eppendorf (UKE) and Heidelberg University Hospital (UKHD) have ...

Although rarely used in the US, it may be time to revisit HRT for women with MS, as it eases overlapping symptoms and offers ...